Sequence: AAVALLPAVLLALLAK
| Experiment Id | EXP002447 |
|---|---|
| Paper | Chemical conjugation of an mRNA cap analogue with a cell-penetrating peptide as a potential membrane |
| Peptide | MPS |
| Delivery Success Class | no |
| In Vivo Flag | no |
| Uptake Confirmed | no |
| Label Confidence | high |
| In Vitro Functional Effect | yes |
| Endosomal Escape Evidence | |
| Peptide Concentration | |
| Rna Concentration | |
| Mixing Ratio | |
| Formulation Format | covalent conjugate |
| Formulation Components | MPS–cap analogue conjugate |
| Size Nm | |
| Zeta Mv | |
| Model Scope | in_vitro |
| Model Type | in vitro |
| Cell Lines Or Primary Cells | Biochemical / cell-free translation systems |
| Animal Model | |
| Administration Route | |
| Output Type | translation inhibition |
| Output Value | Cap analogue inhibits cap-dependent translation in vitro |
| Output Units | |
| Output Notes | Cell permeability discussed; biological testing limited to in vitro systems |
| Toxicity Notes | |
| Curation Notes |